Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I3 | Q14994 | 1/20 | 1.00 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.70 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | SHBG | P04278 | 1/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.63 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.63 |
| ▸ | G6PD | P11413 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | GABRP | O00591 | 1/20 | 0.59 |
| ▸ | GABRD | O14764 | 1/20 | 0.59 |
| ▸ | GMNN | O75496 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1047682 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL15963473 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL3130550 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL3440809 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL13785427 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL11128263 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL21802632 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL20781172 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL20781187 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 | |
| SCHEMBL11250886 | 1.00 | NR1I3 (1.00) | NR1I3CDK5CDK5R1LMNAGPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4430057-A1 | 3.ALPHA.-SUBSTITUTED 3.BETA.-HYDROXY 17-OXIMATED ANDROSTANE COMPOUND FOR MODULATION OF THE ALPHA-3 SUBTYPE OF THE GABA-A RECEPTOR | Umecrine AB (SE) | 2024-09-18 | — | — | EP | claimed |
| WO-2023083978-A1 | 3.ALPHA.-SUBSTITUTED 3.BETA.-HYDROXY 17-OXIMATED ANDROSTANE COMPOUND FOR MODULATION OF THE ALPHA-3 SUBTYPE OF THE GABA-A RECEPTOR | UMECRINE AB (SE) | 2023-05-19 | — | — | WO | claimed |
| EP-1858522-A4 | PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS | NASCENT PHARMACEUTICAL INC (US) | 2008-07-16 | — | — | EP | claimed |
| EP-1858522-A1 | PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS | Nascent Pharmaceutical, Inc. (US) | 2007-11-28 | — | — | EP | claimed |
| WO-2006094026-A1 | PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS | NASCENT PHARMACEUTICALS, INC. (US) | 2006-09-08 | — | — | WO | claimed |
| US-3968132-A | (17R)-Spiro-[androstane-17,1'-cyclobutan]-2'-ones, methods for their manufacture and intermediates useful therein | SCHERING CORPORATION (US) | 1976-07-06 | — | — | US | claimed |
| EP-4430057-A1 | 3.ALPHA.-SUBSTITUTED 3.BETA.-HYDROXY 17-OXIMATED ANDROSTANE COMPOUND FOR MODULATION OF THE ALPHA-3 SUBTYPE OF THE GABA-A RECEPTOR | Umecrine AB (SE) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023083978-A1 | 3.ALPHA.-SUBSTITUTED 3.BETA.-HYDROXY 17-OXIMATED ANDROSTANE COMPOUND FOR MODULATION OF THE ALPHA-3 SUBTYPE OF THE GABA-A RECEPTOR | UMECRINE AB (SE) | 2023-05-19 | — | — | WO | disclosed |
| EP-3016660-A1 | SHIP INHIBITION TO COMBAT OBESITY | The Research Foundation for the State University of New York (US) | 2016-05-11 | — | — | EP | disclosed |
| WO-2015003003-A1 | SHIP INHIBITION TO COMBAT OBESITY | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-01-08 | — | — | WO | disclosed |
| EP-2683730-A1 | ANDROSTANEDIOL DERIVATIVES AS PLANT GROWTH REGULATOR COMPOUNDS | Syngenta Participations AG (CH) | 2014-01-15 | — | — | EP | disclosed |
| EP-2556055-A2 | SHIP INHIBITORS AND USES THEREOF | The Research Foundation of the State University of New York (US) | 2013-02-13 | — | — | EP | disclosed |
| WO-2012123324-A1 | ANDROSTANEDIOL DERIVATIVES AS PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2012-09-20 | — | — | WO | disclosed |
| WO-2011127465-A2 | SHIP INHIBITORS AND USES THEREOF | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 2011-10-13 | — | — | WO | disclosed |
| EP-1858522-A4 | PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS | NASCENT PHARMACEUTICAL INC (US) | 2008-07-16 | — | — | EP | disclosed |
| EP-1858522-A1 | PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS | Nascent Pharmaceutical, Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| EP-1858523-A1 | COMBINAION THERAPY FOR TOPICAL APPLICATION IN THE TREATMENT OF DRY EYE SYNDROME | Nascent Pharmaceutical, Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006094026-A1 | PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS | NASCENT PHARMACEUTICALS, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006094028-A1 | COMBINAION THERAPY FOR TOPICAL APPLICATION IN THE TREATMENT OF DRY EYE SYNDROME | NASCENT PHARMACEUTICALS, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| WO-2004034029-A2 | SCREENING SYSTEMS AND METHODS FOR IDENTIFYING MODULATORS OF XENOBIOTIC METABOLISM | BAYLOR COLLEGE OF MEDICINE (US) | 2004-04-22 | — | — | WO | disclosed |